Navigation Links
Development of an adrenergic α2a receptor binding assay using the LEADseeker Multimodality Imaging System

ppeared to be stable for at least 17 h as demonstrated by the curve in Figure 4.

Z’ analysis
Finally, two independent Z’ analysis (4) evaluations were performed, each using 48 replicate values for "total" and NSB wells. DMSO was present at a final concentration of 1% (v/v) in each well. A mean Z’ value of 0.80 was generated. Figure 5 is representative of the data obtained. This is well within the acceptable Z’ value range (0.5–1.0) and confirmed the robustness of the assay.


Conclusion
The adrenergic α2c receptor binding assay has been successfully miniaturized to a 384-well format using the LEADseeker Multimodality Imaging System and is suitable for adaptation to automated screening formats. The assay is tolerant to DMSO up to a concentration of 1% (v/v), robust; achieving a mean Z’ value of 0.80, and has a stability window of at least 17 h.


References
1. Ruffolo, R. R. Jnr et al. Annual Review Pharmacological Toxicology 32, 243–279 (1993).

2. Hein, L. et al. Nature 402, 181–184 (1999).

3. Bylund, D.B. et al. Pharmacological Reviews 46, 121–136 (1994).

4. Zhang, J. et al. Journal Biomolecular Screening 4 (2), 67–73 (1999).



back to top
'"/>

Source:


Page: All 1 2 3 4

Related biology technology :

1. The let-7 microRNA Family Regulates RAS: Implications for Development and Oncogenesis
2. Rapid Method Development With the BioLogic DuoFlow Chromatography System for the Purification of His-Tagged Proteins
3. A Multiple Mutation Model System as a Test Development and Training Tool for Denaturing Gradient Gel Electrophoresis
4. Development of a Multiplex Bead-Based Assay for Antibody Screening of a Nonhuman Primate Colony on the Bio-Plex System
5. Development of a histamine H1 receptor binding assay using the LEADseeker Multimodality Imaging System
6. Development of a sensitive enzyme fragment complementation assay for cyclic adenosine 3, 5 monophosphate and its validation for pharmacological screening at G protein-coupled receptors
7. Development of an NK2 neuropeptide receptor binding assay using LEADseeker Multimodality Imaging System
8. Development of a CRF1 neuropeptide receptor binding assay using LEADseeker Multimodality Imaging System
9. Development of Radioligand Binding Assays for the Motilin Receptor Using ScreenReady Targets.
10. Screening for potential beta 2-adrenergic receptor antagonists using CypHer5E and IN Cell Analyzer 1000
11. Screening for β2-adrenergic receptor agonists using the pH-sensitive dye,CypHer5, and the IN Cell Analyzer 3000

Post Your Comments:
(Date:11/24/2009)...wire-FirstCall/ -- Sigma-Aldrich Corporation (Nasd...onference on Tuesday, December 1st at 1:45 PM GMT ...listen via live audio broadcast over the Internet ...drich.com/ . Users can click the "Webcast" icon ...: Sigma-Aldrich is a leading Life Science and Hi...
(Date:11/24/2009)...4 NeurogesX, Inc. (Nasda... developing and commercializing novel pain managem...o, President and Chief Executive Officer, is sched...ealth Care Conference, to be held December 1-2, 20...ork. ,, Mr. DiTonno and Stephen Ghiglieri, Chi...
(Date:11/24/2009)...nt has been met for patients with advanced-stage, ...CITY, Nov. 24 /PRNewswire-FirstCall/ - AEterna Zen...y"), a global biopharmaceutical company focused on...ositive efficacy data from a Phase 2 study with it...formerly AN-152), in patients with advanced or rec...
(Date:11/24/2009)...24 Genomic Health, Inc. ... Genomic Health,s Executive Chairman, will present...erence in New York City on Tuesday, December 1, 20... subsequently archived webcast of the presentation...Health,s website at http://investor.genomichealth...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
...terprise accounting system across its US & Chi...AMDL, Inc. (NYSE Alternext US: ADL), a vertically ...in China and the US, announced today it is impleme...ccounting system across its US and China-based ope...International Software, the new accounting system ...
...irst-in-class multivalent therapies for cancer , ...eutics Inc. ("Omnitura") announced today that it h...reement with multiple closings. Under the terms o...e tranches: $8 million before March 31, 2009, $8 m...ore December 31, 2010. "We anticipate that these ...
...ceptive), the industry,s leading eClinical solutio...nal Corporation (Nasdaq: PRXL ), today announced...ion calls placed through its ClinPhone Interactive...years in support of clinical trials for its client...clinical trial functions, including patient enroll...
Other Biology Technology:AMDL First to Implement US & China-Based, GAAP-Certified Accounting Technology to Capitalize on Lucrative China Healthcare Market 2AMDL First to Implement US & China-Based, GAAP-Certified Accounting Technology to Capitalize on Lucrative China Healthcare Market 3AMDL First to Implement US & China-Based, GAAP-Certified Accounting Technology to Capitalize on Lucrative China Healthcare Market 4Omnitura Therapeutics Announces Private Placement Financing 2Perceptive Informatics Reaches Key Milestone Marking 10 Million IVRS Interactions In Support of Clinical Trials 2Perceptive Informatics Reaches Key Milestone Marking 10 Million IVRS Interactions In Support of Clinical Trials 3Perceptive Informatics Reaches Key Milestone Marking 10 Million IVRS Interactions In Support of Clinical Trials 4Perceptive Informatics Reaches Key Milestone Marking 10 Million IVRS Interactions In Support of Clinical Trials 5
(Date:11/24/2009)...el action of a remarkable class of ring-shaped pro... the Lawrence Berkeley National Laboratory (Berkel...graphy beamline at the Advanced Light Source (ALS)...expression and replication, and are vital to the s...ious agents, such as the human papillomavirus, whi...
(Date:11/24/2009)...tes fish food is a matter of debate. A high-profil...most 50 percent of their carbon from trees and lea...rrestrial and aquatic ecosystems. , But new rese...is not likely to be true. Algae provide a much ric...g to research published this week in the Proceedi...
(Date:11/23/2009)...C. The community-associated strain of the deadly ...nt to most common antibioticsposes a far greater h...ts way into hospitals, according to a study in the... , The new threat is easily picked up in fitnes...s increased the overall burden of MRSA within hosp...
Breaking Biology News(10 mins):Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3New study finds MRSA on the rise in hospital outpatients 2Dyslexia varies across language barriers 10322 1Dyslexia varies across language barriers 10322 2American Society of Plastic Surgeons Annual Meeting Photo Op 59290 1American Society of Plastic Surgeons Annual Meeting Photo Op 59290 2American Society of Plastic Surgeons Annual Meeting Photo Op 59290 3Hear Indiana Hosts Hear Here Indianapolis 2009 59285 1Hear Indiana Hosts Hear Here Indianapolis 2009 59285 2Hear Indiana Hosts Hear Here Indianapolis 2009 59285 3
...nomatix Software GmbH, a pioneer and leader in the..., releases MatBase, a knowledge base of transcript...g sites and protein binding domains, related liter...s, experimentally verified complexes with other TF...ns for the DNA binding sites of TFs.In contrast to...
...r smokers with asthma, quitting smoking can improv...t in less than two months. , The findings appear... Journal of Respiratory and Critical Care Medicine...Neil C. Thomson, M.D., of the Departments of Respi...f Glasgow, and seven associates studied 11 asthmat...
...new study by University of Georgia researchers sho...s to control disease outbreaks can actually make m...d the August 7 edition of the journal Proceedings ...doctoral researcher Marc Choisy and Pejman Rohani,... and Health Sciences Institute researcher, create ...
Other Biology News:Quitting smoking improves lung function considerably 2UGA researchers find that hunting can increase the severity of wildlife disease epidemics 2
acridine orange from Molecular Probes (Invitrogen)
DNA Engine Dyad Thermal Cycler Chassis from Bio-Rad
Strip Cap Tool from Bio-Rad
Experion Pro260 Chips, 10 from Bio-Rad
Biology Products: